MDK-4025

CAS No. 66774-02-5

MDK-4025( —— )

Catalog No. M22640 CAS No. 66774-02-5

MDK-4025 is an inhibitor of the high voltage-activated (HVA) Ca2+ current in pyramidal neurons.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 28 In Stock
100MG 37 In Stock
200MG 63 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MDK-4025
  • Note
    Research use only, not for human use.
  • Brief Description
    MDK-4025 is an inhibitor of the high voltage-activated (HVA) Ca2+ current in pyramidal neurons.
  • Description
    MDK-4025 is an inhibitor of the high voltage-activated (HVA) Ca2+ current in pyramidal neurons.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    66774-02-5
  • Formula Weight
    294.78
  • Molecular Formula
    C19H15ClO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(c1ccccc1)(c1ccccc1)c1ccccc1Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.M M Shah , Z Miscony, M Javadzadeh-Tabatabaie, C R Ganellin, D G Haylett,et al.Clotrimazole analogues: effective blockers of the slow afterhyperpolarization in cultured rat hippocampal pyramidal neurones.Br J Pharmacol. 2001 Feb;132(4):889-98.
molnova catalog
related products
  • Felodipine

    Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker.

  • Ticolubant

    Ticolubant is orally active leukotriene B4 antagonist with high affinity for the human neutrophil LTB4 receptor (Ki = 0.78 nM), blocks LTB4-induced Ca2+ migration with an IC50 of 6.6 ± 1.5 nM, and shows topical anti-inflammatory activity in a mouse model of skin inflammation.

  • ACT 709478

    ACT 709478 is a potent, selective, orally-bioavailable, brain penetrant T-type calcium channel blocker with IC50 of 6.4, 18, and 7.5 nM for Cav3.1, Cav3.2, and Cav3.3 channels respectively.